NCT00346554 To Study the Prevalence of Insomnia in Geriatric COPD Patients Who Are Enrolled in a Pulmonary Rehabilitation Program. Status COMPLETED Phase N/A
NCT00323986 Azithromycin Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD) and Tracheostomy Status TERMINATED Phase PHASE2
NCT00308191 A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD Status COMPLETED Phase PHASE3
NCT00299858 Theophylline in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2/PHASE3
NCT00294905 Implementation of an Evidence Based Smoking Cessation Strategy (SMOCC) for Patients With COPD in Primary Care Status TERMINATED Phase NA
NCT00280371 A Trial to Evaluate the Efficacy and Safety of Formoterol Fumarate 20 Mcg/0.5 mL in the Treatment of Patients With COPD Status COMPLETED Phase PHASE3
NCT00276367 The Impact of Post Discharge One-Time Home Visit: Bridging the Gap Between Hospital and Home. Status WITHDRAWN Phase N/A
NCT00263939 Homing in on Health: Study of a Home Delivered Chronic Disease Self Management Program Status COMPLETED Phase NA
NCT00263380 Investigation on the Role of Corticosteroids and Beta-Agonists on Cytokine Production in COPD Patients Status UNKNOWN Phase N/A
NCT00249093 Effects of Supplementary Oxygen on Dyspnoea and Exercise Tolerance in COPD Patients Given LTOT Status COMPLETED Phase NA
NCT00244192 Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia Status COMPLETED Phase PHASE2
NCT00242333 A Study to Assess the Safety and Efficacy of Different AD 237 Doses in Adults With COPD Status COMPLETED Phase PHASE2
NCT00242320 Efficacy and Safety of Oral Roflumilast Taken Once Daily in Patients Older Than 40 Years With Chronic Obstructive Pulmonary Disease (BY217/M2-119) Status COMPLETED Phase PHASE3
NCT00238082 The Effect of QVAR on Lung Functioning in Chronic Obstructive Pulmonary Disease Status TERMINATED Phase NA
NCT00219648 Two-Stage Study to Assess the Efficacy and Safety of 12 Weeks of Treatment With PEP03 in Patients With Chronic Obstructive Pulmonary Disease (COPD) Status UNKNOWN Phase PHASE2